Products & Services
Pioneering modern innovation in the synthesis of peptides and PNAs
SP² Therapeutics is a leader in custom peptide and peptide-PNA (Peptide Nucleic Acid) conjugate synthesis, catering to both NCE (New Chemical Entity) projects and commercial generic APIs (Active Pharmaceutical Ingredients). Beyond research and drug discovery, we provide commercial supply services tailored in purity and size, with swift delivery options. Our comprehensive analytical and process development ensure a secure route to clinical and commercial objectives.
Custom Peptide & Peptide-PNA Conjugate Synthesis
- SP² Therapeutics excels in custom peptide synthesis, including long chains, complex sequences, and peptide PNA conjugates with unique modifications
- Leveraging automated flow chemistry with real-time monitoring, we make our peptide synthesis more efficient than traditional SPPS methods
- We provide research, drug discovery, and commercial supply services with customizable purity and sizes, plus fast delivery for urgent needs
Peptide & Peptide-PNA Conjugate
NCEs
- SP² Therapeutics specializes in research and GMP-grade long-chain peptides and peptide-PNA conjugates for NCE projects
- We offer analytical services and process development to ensure a safe path to clinical and commercial goals within the CMC plan
Commercial
Generic
APIs
- We provide research, drug discovery, and commercial supply services with customizable purity and sizes, plus fast delivery for urgent needs
Our Benchmark: Commercial Generic API’s
| Single Batch Capacity | Crude Yield | Final Yield* | Time to Synthesize | |
|---|---|---|---|---|
| Semaglutide¹ | 100g | 99% | 55% | 12 hrs |
| Tirzapatide¹ | 100g | 99% | 60% | 14 hrs |
| Synthetic EGF’s | 100g | 60% | 25% | 16 hrs |
*Final purity ≥ 99%
¹Research use exemption to patent infringement
Company
Contact
Institute of Molecular Biology & Genetics, Bldg 105, Rm 312, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul, Korea 151-742